Expanded natural product diversity revealed by analysis of lanthipeptide-like gene clusters in Actinobacteria

Applied and Environmental Microbiology

Volumn 81, Issue 13, 2015, Pages 4339-4350

  Zhang, Qi ^a,b   Doroghazi, James R ^a   Zhao, Xiling ^a   Walker, Mark C ^a   van der Donk, Wilfred A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CHEMICAL ANALYSIS; GENES; MACHINERY; PEPTIDES;

ACTINOBACTERIA; BIOSYNTHETIC GENE CLUSTER; BIOSYNTHETIC PATHWAY; CHEMICAL DIVERSITY; DOMAIN TOPOLOGY; LARGE-SCALE ANALYSIS; NATURAL PRODUCTS; POST-TRANSLATIONAL MODIFICATIONS;

BIOSYNTHESIS;

AMINO ACID; BACTERIUM; BIOCHEMISTRY; ENZYME ACTIVITY; GENE EXPRESSION; PEPTIDE;

ACTINOBACTERIA;

ALANINE; BIOLOGICAL PRODUCT; LANTHIONINE; SULFIDE;

ACTINOBACTERIA; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; GENETICS; METABOLISM; MULTIGENE FAMILY;

ACTINOBACTERIA; ALANINE; BIOLOGICAL PRODUCTS; BIOSYNTHETIC PATHWAYS; MULTIGENE FAMILY; SULFIDES;

EID: 84930796627     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00635-15     Document Type: Article

References (75)

1. Willey JM, van der Donk WA. 2007. Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61:477-501. http://dx.doi.org/10.1146/annurev.micro.61.080706.093501.
2. Knerr PJ, van der Donk WA. 2012. Discovery, biosynthesis, and engineering of lantipeptides. Annu Rev Biochem 81:479-505. http://dx.doi.org/10.1146/annurev-biochem-060110-113521.
3. Bierbaum G, Sahl HG. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10:2-18. http://dx.doi.org/10.2174/138920109787048616.
4. Ross AC, Vederas JC. 2011. Fundamental functionality: recent developments in understanding the structure-activity relationships of lantibiotic peptides. J Antibiot 64:27-34. http://dx.doi.org/10.1038/ja.2010.136.
5. Piper C, Cotter PD, Ross RP, Hill C. 2009. Discovery of medically significant lantibiotics. Curr Drug Discov Technol 6:1-18. http://dx.doi.org/10.2174/157016309787581075.
6. Dischinger J, Basi Chipalu S, Bierbaum G. 2014. Lantibiotics: promising candidates for future applications in health care. Int J Med Microbiol 304:51-62. http://dx.doi.org/10.1016/j.ijmm.2013.09.003.
7. Cox CR, Coburn PS, Gilmore MS. 2005. Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci 6:77-84. http://dx.doi.org/10.2174/1389203053027557.
8. Schnell N, Entian KD, Schneider U, Götz F, Zahner H, Kellner R, Jung G. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278. http://dx.doi.org/10.1038/333276a0.
9. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian K-D, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJT, Rebuffat S, et al. 2013. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30:108-160. http://dx.doi.org/10.1039/C2NP20085F.
10. Oman TJ, van der Donk WA. 2010. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol 6:9-18. http://dx.doi.org/10.1038/nchembio.286.
11. Plat A, Kuipers A, Rink R, Moll GN. 2013. Mechanistic aspects of lanthipeptide leaders. Curr Protein Pept Sci 14:85-96. http://dx.doi.org/10.2174/1389203711314020001.
12. Zhang Q, Yu Y, Velásquez JE, van der Donk WA. 2012. Evolution of lanthipeptide synthetases. Proc Natl Acad Sci U S A 109:18361-18366. http://dx.doi.org/10.1073/pnas.1210393109.
13. Siezen RJ, Kuipers OP, de Vos WM. 1996. Comparison of lantibiotic gene clusters and encoded proteins. Antonie Van Leeuwenhoek 69:171-184. http://dx.doi.org/10.1007/BF00399422.
14. Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL, van der Donk WA. 2004. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303:679-681. http://dx.doi.org/10.1126/science.1092600.
15. Müller WM, Schmiederer T, Ensle P, Süssmuth RD. 2010. In vitro biosynthesis of the prepeptide of type-III lantibiotic labyrinthopeptin A2 including formation of a C-C bond as a post-translational modification. Angew Chem Int Ed 49:2436-2440. http://dx.doi.org/10.1002/anie.200905909.
16. Goto Y, Li B, Claesen J, Shi Y, Bibb MJ, van der Donk WA. 2010. Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol 8:e1000339. http://dx.doi.org/10.1371/journal.pbio.1000339.
17. Li B, Yu JP, Brunzelle JS, Moll GN, van der Donk WA, Nair SK. 2006. Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science 311:1464-1467. http://dx.doi.org/10.1126/science.1121422.
18. Tang W, van der Donk WA. 2012. Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria. Biochemistry 51:4271-4279. http://dx.doi.org/10.1021/bi300255s.
19. Zhang Q, Yang X, Wang H, van der Donk WA. 2014. High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis. ACS Chem Biol 9:2686-2694. http://dx.doi.org/10.1021/cb500622c.
20. Begley M, Cotter PD, Hill C, Ross RP. 2009. Rational genome mining for LanM proteins leads to the identification of a novel two-peptide lantibiotic, lichenicidin. Appl Environ Microbiol 75:5451-5460. http://dx.doi.org/10.1128/AEM.00730-09.
21. Marsh AJ, O'Sullivan O, Ross RP, Cotter PD, Hill C. 2010. In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics 11:679. http://dx.doi.org/10.1186/1471-2164-11-679.
22. Singh M, Sareen D. 2014. Novel LanT associated lantibiotic clusters identified by genome database mining. PLoS One 9:e91352. http://dx.doi.org/10.1371/journal.pone.0091352.
23. Doroghazi JR, Albright JC, Goering AW, Ju KS, Haines RR, Tchalukov KA, Labeda DP, Kelleher NL, Metcalf WW. 2014. A roadmap for natural product discovery based on large-scale genomics and metabolomics. Nat Chem Biol 10:963-968. http://dx.doi.org/10.1038/nchembio.1659.
24. Berdy J. 2005. Bioactive microbial metabolites. J Antibiot 58:1-26. http://dx.doi.org/10.1038/ja.2005.1.
25. Monciardini P, Iorio M, Maffioli S, Sosio M, Donadio S. 2014. Discovering new bioactive molecules from microbial sources. Microb Biotechnol 7:209-220. http://dx.doi.org/10.1111/1751-7915.12123.
26. Okesli A, Cooper LE, Fogle EJ, van der Donk WA. 2011. Nine posttranslational modifications during the biosynthesis of cinnamycin. J Am Chem Soc 133:13753-13760. http://dx.doi.org/10.1021/ja205783f.
27. Foulston LC, Bibb MJ. 2010. Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes. Proc Natl Acad Sci U S A 107:13461-13466. http://dx.doi.org/10.1073/pnas.1008285107.
28. Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F. 2008. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 15:22-31. http://dx.doi.org/10.1016/j.chembiol.2007.11.009.
29. Maffioli SI, Iorio M, Sosio M, Monciardini P, Gaspari E, Donadio S. 2014. Characterization of the congeners in the lantibiotic NAI-107 complex. J Nat Prod 77:79-84. http://dx.doi.org/10.1021/np400702t.
30. Iorio M, Sasso O, Maffioli SI, Bertorelli R, Monciardini P, Sosio M, Bonezzi F, Summa M, Brunati C, Bordoni R, Corti G, Tarozzo G, Piomelli D, Reggiani A, Donadio S. 2014. A glycosylated, labionincontaining lanthipeptide with marked antinociceptive activity. ACS Chem Biol 9:398-404. http://dx.doi.org/10.1021/cb400692w.
31. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD. 2007. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2:2366-2382. http://dx.doi.org/10.1038/nprot.2007.324.
32. Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res 14:1188-1190. http://dx.doi.org/10.1101/gr.849004.
33. Ross AC, Liu H, Pattabiraman VR, Vederas JC. 2010. Synthesis of the lantibiotic lactocin S using peptide cyclizations on solid phase. JAmChem Soc 132:462-463. http://dx.doi.org/10.1021/ja9095945.
34. Doroghazi JR, Metcalf WW. 2013. Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes. BMC Genomics 14:611. http://dx.doi.org/10.1186/1471-2164-14-611.
35. Doroghazi JR, Buckley DH. 2014. Intraspecies comparison of Streptomyces pratensis genomes reveals high levels of recombination and gene conservation between strains of disparate geographic origin. BMC Genomics 15:970. http://dx.doi.org/10.1186/1471-2164-15-970.
36. Yu Y, Zhang Q, van der Donk WA. 2013. Insights into the evolution of lanthipeptide biosynthesis. Protein Sci 22:1478-1489. http://dx.doi.org/10.1002/pro.2358.
37. Lawton EM, Ross RP, Hill C, Cotter PD. 2007. Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem 7:1236-1247. http://dx.doi.org/10.2174/138955707782795638.
38. Meindl K, Schmiederer T, Schneider K, Reicke A, Butz D, Keller S, Guhring H, Vertesy L, Wink J, Hoffmann H, Bronstrup M, Sheldrick GM, Süssmuth RD. 2010. Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl 49:1151-1154. http://dx.doi.org/10.1002/anie.200905773.
39. Völler GH, Krawczyk JM, Pesic A, Krawczyk B, Nachtigall J, Süssmuth RD. 2012. Characterization of new class III lantibiotics- erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing. Chembiochem 13:1174-1183. http://dx.doi.org/10.1002/cbic.201200118.
40. Oldach F, Al Toma R, Kuthning A, Caetano T, Mendo S, Budisa N, Süssmuth RD. 2012. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. Angew Chem Int Ed Engl 51:415-418. http://dx.doi.org/10.1002/anie.201106154.
41. Wang H, van der Donk WA. 2012. Biosynthesis of the class III lantipeptide catenulipeptin. ACS Chem Biol 7:1529-1535. http://dx.doi.org/10.1021/cb3002446.
42. Krawczyk JM, Völler GH, Krawczyk B, Kretz J, Brönstrup M, Süssmuth RD. 2013. Heterologous expression and engineering studies of labyrinthopeptins, class III lantibiotics from Actinomadura namibiensis. Chem Biol 20: 111-122. http://dx.doi.org/10.1016/j.chembiol.2012.10.023.
43. Sofia HJ, Chen G, Hetzler BG, Reyes-Spindola JF, Miller NE. 2001. Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res 29:1097-1106. http://dx.doi.org/10.1093/nar/29.5.1097.
44. Frey PA, Hegeman AD, Ruzicka FJ. 2008. The radical SAM superfamily. Crit Rev Biochem Mol Biol 43:63-88. http://dx.doi.org/10.1080/10409230701829169.
45. Cotter PD, O'Connor PM, Draper LA, Lawton EM, Deegan LH, Hill C, Ross RP. 2005. Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci U S A 102:18584-18589. http://dx.doi.org/10.1073/pnas.0509371102.
46. Suda S, Lawton EM, Wistuba D, Cotter PD, Hill C, Ross RP. 2012. Homologues and bioengineered derivatives of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin 3147. J Bacteriol 194:708-714. http://dx.doi.org/10.1128/JB.06185-11.
47. Lohans CT, Li J L, Vederas JC. 2014. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids. J Am Chem Soc 136:13150-13153. http://dx.doi.org/10.1021/ja5070813.
48. McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, van der Donk WA. 2006. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A 103:17243-17248. http://dx.doi.org/10.1073/pnas.0606088103.
49. Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G. 2009. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One 4:e6788. http://dx.doi.org/10.1371/journal.pone.0006788.
50. Shenkarev ZO, Finkina EI, Nurmukhamedova EK, Balandin SV, Mineev KS, Nadezhdin KD, Yakimenko ZA, Tagaev AA, Temirov YV, Arseniev AS, Ovchinnikova TV. 2010. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry 49:6462-6472. http://dx.doi.org/10.1021/bi100871b.
51. Caetano T, Krawczyk JM, Mosker E, Süssmuth RD, Mendo S. 2011. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol 18:90-100. http://dx.doi.org/10.1016/j.chembiol.2010.11.010.
52. Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A. 2007. Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. Nat Prod Rep 24:162-190. http://dx.doi.org/10.1039/B507395M.
53. Cupp-Vickery JR, Poulos TL. 1995. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol 2:144-153. http://dx.doi.org/10.1038/nsb0295-144.
54. Ortega MA, Hao Y, Zhang Q, Walker MC, van der Donk WA, Nair SK. 2015. Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB. Nature 517:509-512. http://dx.doi.org/10.1038/nature13888.
55. Noike M, Matsui T, Ooya K, Sasaki I, Ohtaki S, Hamano Y, Maruyama C, Ishikawa J, Satoh Y, Ito H, Morita H, Dairi T. 2015. A peptide ligase and the ribosome cooperate to synthesize the peptide pheganomycin. Nat Chem Biol 11:71-76. http://dx.doi.org/10.1038/nchembio.1697.
56. Chung CHY, Kurien BT, Mehta P, Mhatre M, Mou S, Pye Q N, Stewart C, West M, Williamson KS, Post J, Liu L, Wang R, Hensley K. 2007. Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry 46:3262-3269. http://dx.doi.org/10.1021/bi061888s.
57. Hensley K, Venkova K, Christov A. 2010. Emerging biological importance of central nervous system lanthionines. Molecules 15:5581-5594. http://dx.doi.org/10.3390/molecules15085581.
58. Zhong WX, Wang YB, Peng L, Ge XZ, Zhang J, Liu SS, Zhang XN, Xu ZH, Chen Z, Luo JH. 2012. Lanthionine synthetase C-like protein 1 interacts with and inhibits cystathionine beta-synthase: a target for neuronal antioxidant defense. J Biol Chem 287:34189-34201. http://dx.doi.org/10.1074/jbc.M112.383646.
59. Zhang W, Wang L, Liu Y, Xu J, Zhu G, Cang H, Li X, Bartlam M, Hensley K, Li G, Rao Z, Zhang XC. 2009. Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev 23:1387-1392. http://dx.doi.org/10.1101/gad.1789209.
60. Huang C, Chen M, Pang D, Bi D, Zou Y, Xia X, Yang W, Luo L, Deng R, Tan H, Zhou L, Yu S, Guo L, Du X, Cui Y, Hu J, Mao Q, Worley PF, Xiao B. 2014. Developmental and activity-dependent expression of LanCL1 confers antioxidant activity required for neuronal survival. Dev Cell 30:479-487. http://dx.doi.org/10.1016/j.devcel.2014.06.011.
61. Zeng M, van der Donk WA, Chen J. 2014. Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt. Mol Biol Cell 25:3954-3961. http://dx.doi.org/10.1091/mbc.E14-01-0004.
62. Dunwell JM, Purvis A, Khuri S. 2004. Cupins: the most functionally diverse protein superfamily? Phytochemistry 65:7-17. http://dx.doi.org/10.1016/j.phytochem.2003.08.016.
63. Freeman MF, Gurgui C, Helf MJ, Morinaka BI, Uria AR, Oldham NJ, Sahl HG, Matsunaga S, Piel J. 2012. Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides. Science 338:387-390. http://dx.doi.org/10.1126/science.1226121.
64. Melby JO, Nard NJ, Mitchell DA. 2011. Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates. Curr Opin Chem Biol 15:369-378. http://dx.doi.org/10.1016/j.cbpa.2011.02.027.
65. Bagley MC, Dale JW, Merritt EA, Xiong X. 2005. Thiopeptide antibiotics. Chem Rev 105:685-714. http://dx.doi.org/10.1021/cr0300441.
66. Li C, Kelly WL. 2010. Recent advances in thiopeptide antibiotic biosynthesis. Nat Prod Rep 27:153-164. http://dx.doi.org/10.1039/B922434C.
67. Walsh CT, Malcolmson SJ, Young TS. 2012. Three ring posttranslational circuses: insertion of oxazoles, thiazoles, and pyridines into proteinderived frameworks. ACS Chem Biol 7:429-442. http://dx.doi.org/10.1021/cb200518n.
68. Dunbar KL, Chekan JR, Cox CL, Burkhart BJ, Nair SK, Mitchell DA. 2014. Discovery of a new ATP-binding motif involved in peptidic azoline biosynthesis. Nat Chem Biol 10:823-829. http://dx.doi.org/10.1038/nchembio.1608.
69. Schmidt EW, Nelson JT, Rasko DA, Sudek S, Eisen JA, Haygood MG, Ravel J. 2005. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc Natl Acad Sci U S A 102:7315-7320. http://dx.doi.org/10.1073/pnas.0501424102.
70. Sivonen K, Leikoski N, Fewer DP, Jokela J. 2010. Cyanobactins- ribosomal cyclic peptides produced by cyanobacteria. Appl Microbiol Biotechnol 86:1213-1225. http://dx.doi.org/10.1007/s00253-010-2482-x.
71. Zhang Q, Liu W. 2013. Biosynthesis of thiopeptide antibiotics and their pathway engineering. Nat Prod Rep 30:218-226. http://dx.doi.org/10.1039/C2NP20107K.
72. Li YM, Milne JC, Madison LL, Kolter R, Walsh CT. 1996. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase. Science 274:1188-1193. http://dx.doi.org/10.1126/science.274.5290.1188.
73. Krawczyk B, Völler GH, Völler J, Ensle P, Süssmuth RD. 2012. Curvopeptin: a new lanthionine-containing class III lantibiotic and its cosubstrate promiscuous synthetase. Chembiochem 13:2065-2071. http://dx.doi.org/10.1002/cbic.201200417.
74. Iorio M, Sasso O, Maffioli SI, Bertorelli R, Monciardini P, Sosio M, Bonezzi F, Summa M, Brunati C, Bordoni R, Corti G, Tarozzo G, Piomelli D, Reggiani A, Donadio S. 2014. A glycosylated, labionincontaining lanthipeptide with marked antinociceptive activity. ACS Chem Biol 9:398. http://dx.doi.org/10.1021/cb400692w.
75. Willey JM, Gaskell AA. 2011. Morphogenetic signaling molecules of the streptomycetes. Chem Rev 111:174-187. http://dx.doi.org/10.1021/cr1000404.